Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3187)
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
100,000
Price
$6.06
Total Value
$606.00K
Shares Held After
254,535
% of Holdings
28.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Shares
50
Price
$26.17
Total Value
$1.31K
Shares Held After
18,994
% of Holdings
0.3%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Shares
16,508
Price
$26.13
Total Value
$431.35K
Shares Held After
19,044
% of Holdings
46.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$528.96
Total Value
$21.16K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$526.92
Total Value
$210.77K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,084
Price
$525.80
Total Value
$1.10M
Shares Held After
324,883
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,846
Price
$524.88
Total Value
$2.54M
Shares Held After
326,967
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$523.87
Total Value
$778.48K
Shares Held After
331,813
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
644
Price
$523.04
Total Value
$336.84K
Shares Held After
333,299
% of Holdings
0.2%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
500
Price
$48.90
Total Value
$24.45K
Shares Held After
1,078
% of Holdings
31.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$48.90
Total Value
$122.25K
Shares Held After
1,078
% of Holdings
69.9%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
1,500
Price
$48.90
Total Value
$73.35K
Shares Held After
1,078
% of Holdings
58.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
121,338
% of Holdings
3.1%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,845
Price
$23.38
Total Value
$66.52K
Shares Held After
44,927
% of Holdings
6.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
19,912
% of Holdings
16.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
14,000
Price
$79.88
Total Value
$1.12M
Shares Held After
58,555
% of Holdings
19.3%
DBV Technologies S.A. (DBVT)
Mohideen Pharis — Chief Medical Officer
Shares
464
Price
$2.70
Total Value
$1.25K
Shares Held After
144,531
% of Holdings
0.3%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
400
Price
$27.89
Total Value
$11.16K
Shares Held After
26,250
% of Holdings
1.5%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,100
Price
$27.31
Total Value
$193.88K
Shares Held After
26,650
% of Holdings
21.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Cole G Bradley — Director
Shares
3,673
Price
$81.43
Total Value
$299.09K
Shares Held After
11,672
% of Holdings
23.9%
PROTHENA CORP PUBLIC LTD CO (PRTA)
Isaacs Michael John — General Counsel&Company Sec.
Shares
8,386
Price
$8.47
Total Value
$71.06K
Shares Held After
35,745
% of Holdings
19.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
Kingston Anne Evans — Chief Strategy Officer
Shares
7,662
Price
$8.47
Total Value
$64.92K
Shares Held After
55,782
% of Holdings
12.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,240
Price
$525.46
Total Value
$651.57K
Shares Held After
324,443
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,982
Price
$524.47
Total Value
$1.04M
Shares Held After
325,683
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,318
Price
$523.62
Total Value
$690.14K
Shares Held After
327,665
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$522.51
Total Value
$459.81K
Shares Held After
328,983
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,270
Price
$521.32
Total Value
$662.08K
Shares Held After
329,863
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
900
Price
$520.40
Total Value
$468.36K
Shares Held After
331,133
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,112
Price
$519.29
Total Value
$577.45K
Shares Held After
332,033
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
798
Price
$518.25
Total Value
$413.56K
Shares Held After
333,145
% of Holdings
0.2%
Viking Therapeutics, Inc. (VKTX)
Mancini Marianna — Chief Operating Officer
Shares
18,217
Price
$33.47
Total Value
$609.64K
Shares Held After
422,760
% of Holdings
4.1%
Viking Therapeutics, Inc. (VKTX)
Lian Brian — Director
Shares
148,517
Price
$33.32
Total Value
$4.95M
Shares Held After
2,572,441
% of Holdings
5.5%
Viking Therapeutics, Inc. (VKTX)
ZANTE GREG — Chief Financial Officer
Shares
21,217
Price
$33.47
Total Value
$710.14K
Shares Held After
212,204
% of Holdings
9.1%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Cheif Corporate Development Officer
Shares
748
Price
$18.61
Total Value
$13.92K
Shares Held After
228,165
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Poulton Stuart — EVP, Chief Development Officer
Shares
189
Price
$7.10
Total Value
$1.34K
Shares Held After
94,632
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,237
Price
$18.61
Total Value
$41.63K
Shares Held After
407,660
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,459
Price
$18.61
Total Value
$27.15K
Shares Held After
158,285
% of Holdings
0.9%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
4,928
Price
$2.67
Total Value
$13.16K
Shares Held After
62,369
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.49
Total Value
$21.30K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
403
Price
$530.97
Total Value
$213.98K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,124
Price
$530.29
Total Value
$596.05K
Shares Held After
324,886
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$529.41
Total Value
$330.88K
Shares Held After
326,010
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$528.20
Total Value
$606.90K
Shares Held After
326,635
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,369
Price
$527.16
Total Value
$721.68K
Shares Held After
327,784
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,473
Price
$526.34
Total Value
$775.29K
Shares Held After
329,153
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$525.02
Total Value
$459.92K
Shares Held After
330,626
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,074
Price
$524.04
Total Value
$562.82K
Shares Held After
331,502
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,367
Price
$523.15
Total Value
$715.15K
Shares Held After
332,576
% of Holdings
0.4%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$34.95
Total Value
$6.99M
Shares Held After
1,613,063
% of Holdings
11.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$87.53
Total Value
$60.22K
Shares Held After
216,438
% of Holdings
0.3%
Showing 1–50 of 3187 transactions (page 1 of 64)